Vor Biopharma Inc (VOR)
0.79
-0.01
(-0.77%)
USD |
NASDAQ |
Nov 22, 16:00
0.79
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Cash from Investing (Quarterly): -0.034M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.034M |
| June 30, 2024 | 52.99M |
| March 31, 2024 | 43.97M |
| December 31, 2023 | 10.34M |
| September 30, 2023 | 40.54M |
| June 30, 2023 | 13.64M |
| March 31, 2023 | 6.498M |
| December 31, 2022 | -97.04M |
| September 30, 2022 | 12.70M |
| June 30, 2022 | -2.702M |
| Date | Value |
|---|---|
| March 31, 2022 | -7.055M |
| December 31, 2021 | -5.953M |
| September 30, 2021 | -8.486M |
| June 30, 2021 | -76.04M |
| March 31, 2021 | -1.171M |
| December 31, 2020 | -1.477M |
| September 30, 2020 | -1.587M |
| June 30, 2020 | -0.552M |
| March 31, 2020 | -0.545M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-97.04M
Minimum
Dec 2022
52.99M
Maximum
Jun 2024
-1.156M
Average
-0.552M
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| Organon & Co | -75.00M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.713M |
| Theriva Biologics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.28M |
| Cash from Financing (Quarterly) | 0.041M |
| Free Cash Flow | -99.89M |
| Free Cash Flow Per Share (Quarterly) | -0.3406 |
| Free Cash Flow Yield | -185.5% |